Literature DB >> 15166804

Associations of low density lipoprotein particle composition with atherogenicity.

Aaron T Lada1, Lawrence L Rudel.   

Abstract

PURPOSE OF REVIEW: A growing body of data suggests that in addition to LDL-cholesterol concentrations, compositional properties of LDL, including size and fatty acid composition, are important in determining the relative degree of atherogenicity. This review examines current research in this field to evaluate which properties of LDL may most directly influence the risk of coronary heart disease. RECENT
FINDINGS: The presence of small dense LDL has been correlated with an increased risk of coronary heart disease, but this has not been shown to be fully independent of related factors such as elevated plasma triacylglycerol concentrations. An increased susceptibility of small dense LDL to in-vitro oxidation has also been demonstrated, but its importance to coronary heart disease risk has not been established. Other studies have found that the presence of enlarged LDL, modified (oleate enriched) fatty acyl composition of LDL, and higher numbers of LDL particles in plasma also are endpoints associated with an increased risk of coronary heart disease.
SUMMARY: LDL size may indicate a metabolic condition associated with increased CHD risk as opposed to the direct promotion of atherosclerosis by specific particle types of LDL. In most claims of detrimental effects of small dense LDL, neither LDL particle concentrations nor the fatty acid composition of the particles were established, both factors being important in contributing to the atherogenic potential of LDL. The predisposition to premature coronary heart disease cannot currently be objectively assigned to any one type of LDL particle.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15166804     DOI: 10.1097/00041433-200402000-00005

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  14 in total

1.  Profound influence of LDL oxidative status and monocyte co-cultures on baboon endothelial activation.

Authors:  Juan Xiao; Vida Hondara; Xing Li Wang; John L Vandeberg; Qiang Shi
Journal:  Am J Cardiovasc Dis       Date:  2011-12-15

Review 2.  Is it LDL particle size or number that correlates with risk for cardiovascular disease?

Authors:  H Robert Superko; Radhika R Gadesam
Journal:  Curr Atheroscler Rep       Date:  2008-10       Impact factor: 5.113

Review 3.  Metabolic syndrome: A review of the role of vitamin D in mediating susceptibility and outcome.

Authors:  Richard C Strange; Kate E Shipman; Sudarshan Ramachandran
Journal:  World J Diabetes       Date:  2015-07-10

4.  High-oleic canola oil consumption enriches LDL particle cholesteryl oleate content and reduces LDL proteoglycan binding in humans.

Authors:  Peter J H Jones; Dylan S MacKay; Vijitha K Senanayake; Shuaihua Pu; David J A Jenkins; Philip W Connelly; Benoît Lamarche; Patrick Couture; Penny M Kris-Etherton; Sheila G West; Xiaoran Liu; Jennifer A Fleming; Roy R Hantgan; Lawrence L Rudel
Journal:  Atherosclerosis       Date:  2014-12-09       Impact factor: 5.162

Review 5.  Oxidized low-density lipoprotein.

Authors:  Sampath Parthasarathy; Achuthan Raghavamenon; Mahdi Omar Garelnabi; Nalini Santanam
Journal:  Methods Mol Biol       Date:  2010

6.  Estrogen decreases atherosclerosis in part by reducing hepatic acyl-CoA:cholesterol acyltransferase 2 (ACAT2) in monkeys.

Authors:  Kylie Kavanagh; Matthew A Davis; Li Zhang; Martha D Wilson; Thomas C Register; Michael R Adams; Lawrence L Rudel; Janice D Wagner
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-10       Impact factor: 8.311

7.  Genetic analysis of 16 NMR-lipoprotein fractions in humans, the GOLDN study.

Authors:  Aldi T Kraja; Ingrid B Borecki; Michael Y Tsai; Jose M Ordovas; Paul N Hopkins; Chao-Qiang Lai; Alexis C Frazier-Wood; Robert J Straka; James E Hixson; Michael A Province; Donna K Arnett
Journal:  Lipids       Date:  2012-11-29       Impact factor: 1.880

8.  Lipoprotein particle profiles mark familial and sporadic human longevity.

Authors:  Bastiaan T Heijmans; Marian Beekman; Jeanine J Houwing-Duistermaat; Mark R Cobain; Jonathan Powell; Gerard Jan Blauw; Frans van der Ouderaa; Rudi G J Westendorp; P Eline Slagboom
Journal:  PLoS Med       Date:  2006-12       Impact factor: 11.069

9.  ApoE plasma levels and risk of cardiovascular mortality in old age.

Authors:  Simon P Mooijaart; Jimmy F P Berbée; Diana van Heemst; Louis M Havekes; Anton J M de Craen; P Eline Slagboom; Patrick C N Rensen; Rudi G J Westendorp
Journal:  PLoS Med       Date:  2006-05-09       Impact factor: 11.069

10.  The joint effects of apolipoprotein B, apolipoprotein A1, LDL cholesterol, and HDL cholesterol on risk: 3510 cases of acute myocardial infarction and 9805 controls.

Authors:  Sarah Parish; Richard Peto; Alison Palmer; Robert Clarke; Sarah Lewington; Alison Offer; Gary Whitlock; Sarah Clark; Linda Youngman; Peter Sleight; Rory Collins
Journal:  Eur Heart J       Date:  2009-06-11       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.